All In Biotech

Drug Trial Radar · NCT06876714

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

ShortStop-HER2: Shortened Duration of Adjuvant Therapy in Patients With Early-Stage HER2+ Breast Cancer Who Achieve pCR After Neoadjuvant Chemotherapy With HER2 Blockade

Last checked: Nov 20, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,524 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,524

Planned (sponsor's estimate)

Start

Sep 17, 2025

Primary completion

Mar 13, 2028

Study completion Mar 13, 2037

Sponsor

Lead sponsor
Alliance for Clinical Trials in OncologyAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Cancer Institute (NCI)
First posted
Mar 14, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase III trial compares 6 months of human epidermal growth factor receptor 2 (HER2)-targeted therapy to 12 months of HER2-targeted therapy for the treatment of HER2-positive (+) breast cancer in patients that had a pathologic complete response (pCR) after preoperative (neoadjuvant) chemotherapy with trastuzumab. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called HER2. HER2 is found on some cancer cells. When trastuzumab or pertuzumab attach to HER2, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Giving 6 months of HER2-targeted therapy may work better than giving 12 months for the treatment of HER2+ breast cancer in patients that had a pCR after neoadjuvant chemotherapy with trastuzumab.

Conditions

  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Early Stage HER2+ Breast Cancer

Interventions

  • Trastuzumab (Herceptin)Biological

    Given IV or SC

  • PertuzumabBiological

    Given IV or SC

  • EchocardiographyProcedure

    Undergo ECHO

  • Multigated Acquisition ScanProcedure

    Undergo MUGA

  • MammographyProcedure

    Undergo mammography

  • UltrasoundProcedure

    Undergo ultrasound

  • Magnetic Resonance ImagingProcedure

    Undergo MRI

  • Biospecimen CollectionProcedure

    Undergo blood and tissue sample collection

  • Questionnaire AdministrationOther

    Ancillary studies

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Recurrence-free survival (RFS)Time frame: From randomization to invasive local, regional or distant breast cancer recurrence, or death from any cause prior to a documented disease recurrence, assessed up to 10 years
  2. Functional Assessment of Cancer Therapy-Breast (FACT-B) total score (Quality of life)Time frame: At 12 months

Locations

702 sites in 2 countries. Site status is shown where the registry gives one.

  • Cancer Center at Saint Joseph's

    Phoenix, Arizona · Suspended

  • Mayo Clinic Hospital in Arizona

    Phoenix, Arizona · Recruiting

  • Mercy Hospital Fort Smith

    Fort Smith, Arkansas · Suspended

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro

    Jonesboro, Arkansas · Recruiting

  • CARTI Cancer Center

    Little Rock, Arkansas · Suspended

  • Mission Hope Medical Oncology - Arroyo Grande

    Arroyo Grande, California · Suspended

  • Tower Cancer Research Foundation

    Beverly Hills, California · Recruiting

  • Mercy Cancer Center - Carmichael

    Carmichael, California · Recruiting

  • Mercy San Juan Medical Center

    Carmichael, California · Recruiting

  • Enloe Medical Center

    Chico, California · Recruiting

  • Kaiser Permanente Dublin

    Dublin, California · Recruiting

  • Mercy Cancer Center - Elk Grove

    Elk Grove, California · Recruiting

  • Stanford Cancer Center Emeryville

    Emeryville, California · Recruiting

  • Kaiser Permanente-Fremont

    Fremont, California · Recruiting

  • Washington Health

    Fremont, California · Recruiting

  • Kaiser Permanente Fresno Orchard Plaza

    Fresno, California · Recruiting

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care

    Irvine, California · Recruiting

  • UC San Diego Moores Cancer Center

    La Jolla, California · Recruiting

  • Loma Linda University Medical Center

    Loma Linda, California · Recruiting

  • Fremont - Rideout Cancer Center

    Marysville, California · Recruiting

  • Mercy Cancer Center

    Merced, California · Suspended

  • Kaiser Permanente- Modesto MOB II

    Modesto, California · Recruiting

  • Kaiser Permanente-Modesto

    Modesto, California · Recruiting

  • Kaiser Permanente-Oakland

    Oakland, California · Recruiting

  • UC Irvine Health/Chao Family Comprehensive Cancer Center

    Orange, California · Recruiting

  • Stanford Cancer Institute Palo Alto

    Palo Alto, California · Recruiting

  • Huntington Memorial Hospital

    Pasadena, California · Recruiting

  • Eisenhower Medical Center

    Rancho Mirage, California · Recruiting

  • Mercy Cancer Center - Rocklin

    Rocklin, California · Recruiting

  • Kaiser Permanente-Roseville

    Roseville, California · Recruiting

  • Kaiser Permanente Downtown Commons

    Sacramento, California · Recruiting

  • Mercy Cancer Center - Sacramento

    Sacramento, California · Recruiting

  • University of California Davis Comprehensive Cancer Center

    Sacramento, California · Recruiting

  • Kaiser Permanente-South Sacramento

    Sacramento, California · Recruiting

  • Salinas Valley Memorial

    Salinas, California · Recruiting

  • UC San Diego Medical Center - Hillcrest

    San Diego, California · Recruiting

  • Kaiser Permanente-San Francisco

    San Francisco, California · Recruiting

  • Kaiser Permanente-Santa Teresa-San Jose

    San Jose, California · Recruiting

  • Stanford Cancer Center South Bay

    San Jose, California · Recruiting

  • Kaiser Permanente San Leandro

    San Leandro, California · Recruiting

Showing 40 of 702 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.